After performing an “in-depth analysis,” a group of ERISA lawyers at Drinker Biddle & Reath have sent a letter to the 401(k) community debunking a recent Yale professor’s claim that they had breached their fiduciary duties with respect to plan costs and investments.
In his letter, sent in mid-July to 6,000 sponsors of 401(k) plans, Ian Ayres, a William K. Townsend professor at Yale Law School, suggested that the recipients were operating a “potentially high-cost plan” and that they may have breached their fiduciary duties.
In some of the letters, Ayres also said that he intended to publicize his study on plan expenses next spring.
But Fred Reish, partner and chair of the financial services ERISA team at Drinker Biddle & Reath, told ThinkAdvisor on Tuesday that because “a number of people” have written to Ayers as well as to Yale University noting their concerns about the report and the quality of the underlying data, as well as its results, “My understanding is that the professor has agreed that, while he will release the study together with aggregated information, he no longer plans to release information about individual plans.”
10 Best Telecom Stocks To Own Right Now: Lamar Advertising Company(LAMR)
Lamar Advertising Company, together with its subsidiaries, provides outdoor advertising services. Its outdoor advertising displays include billboards, such as bulletins, posters, and digital billboards; and logo signs to advertise nearby gas, food, camping, lodging, and other attractions. The company also offers transit advertising displays that provide advertising space on the exterior and interior of public transportation vehicles, transit shelters, and benches. As of December 31, 2011, it owned and operated approximately 143,000 billboard advertising displays in 44 states, Canada, and Puerto Rico; operated approximately 112,000 logo advertising displays in 21 states and the province of Ontario, Canada; operated approximately 30,000 transit advertising displays in 16 states, Canada, and Puerto Rico; and owned and operated approximately 1,400 digital billboard advertising displays in 40 states, Canada, and Puerto Rico. The company was founded in 1989 and is headquartered in Baton Rouge, Louisiana.
Advisors' Opinion:- [By Tess Stynes var popups = dojo.query(".socialByline .popC"); popups.forEach(fu]
Lamar Advertising Co.'s(LAMR) first-quarter loss narrowed as the outdoor advertising company posted stronger revenue. However, revenue missed expectations. Shares fell 1.7% to $48.82 premarket.
- [By Steven Russolillo]
WATCH FOR: First-Quarter Productivity (8:30 a.m. Eastern Time): seen -1.1%; previously +1.8%. First-Quarter Unit Labor Costs (8:30): seen +2.8%; previously -0.1%. March Consumer Credit (3:00): seen +$16.1 B; previously $16.5B. Allergan(AGN), AOL(AOL), Avis Budget(CAR), CenturyLink, Chesapeake Energy(CHK), CF Industries(CF), Devon Energy(DVN), Duke Energy(DUK), Dynergy, Hertz, Humana, Keurig Green Mountain(GMCR), Lamar Advertising(LAMR), Molson Coors/Miller, Mondelez, Prudential, SolarCity(SCTY), Sotheby's(BID), Tesla Motors(TSLA), Transocean and 21st Century Fox are among companies scheduled to report quarterly results.
- [By Sean Williams]
In addition to Interpublic, noted above, three other notable pure-play companies you can invest in within the advertising space are Lamar Advertising (NASDAQ: LAMR ) , Omnicom Group (NYSE: OMC ) , and CBS Outdoor Americas (NYSE: CBSO ) .�
- [By Paul Ausick]
CBS Outdoor Americas Inc. is currently a wholly owned subsidiary of CBS Corp. (NYSE: CBS) which will offer 20 million shares in an anticipated price range of $26 to $28 a share. Following the tax-free spin-off, CBS Outdoor will become a REIT. CBS first announced plans for the spin-off in January 2013. Since then, share prices for outdoor advertising firms Lamar Advertising Co. (NASDAQ: LAMR) and Clear Channel Outdoor Holdings Inc. (NYSE: CCO) have risen about 30%.
Top 5 Services Companies To Buy Right Now: Point.360(PTSX)
Point.360 operates as an integrated media management services company in the United States. It offers film, video and audio post-production, archival, duplication, computer graphics, and data distribution services. The company also provides services to edit, master, reformat, covert, archive, and distribute its clients? film and video content, including television programming, feature films, and movie trailers. Its value-added services comprise visual effects, video and data editing, graphics and animation, digital color correction, picture restoration, audio post-production, audio restoration and layback, closed captioning and subtitling, foreign language mastering, standards conversion, broadcast encoding, global distribution and syndication, and archival services. In addition, Point.360 is involved in the rental and sale of DVDs and video games to consumers through its Movie>Q retail stores. Its customers include independent motion picture and television production com panies, television program suppliers, national television networks, infomercial providers, local television stations, television program syndicators, corporations, and educational institutions, as well as advertising agencies, and corporate or instructional video providers. The company is based in Burbank, California.
Advisors' Opinion:- [By Lisa Levin]
Point.360 (NASDAQ: PTSX) shares reached a new 52-week low of $0.528. Point.360's trailing-twelve-month ROE is -12.69%.
QC Holdings (NASDAQ: QCCO) shares tumbled 3.68% to reach a new 52-week low of $1.83. QC Holdings shares have dropped 42.60% over the past 52 weeks, while the S&P 500 index has gained 31.67% in the same period.
Top 5 Services Companies To Buy Right Now: Bed Bath & Beyond Inc.(BBBY)
Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestic merchandise, such as bed linens and related items, bath items, and kitchen textiles; and home furnishings, including kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and certain juvenile products. The company also offers giftware, household products, and health and beauty care items; and infant and toddler merchandise. It operates stores under the names of Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon), and buybuy BABY. As of August 27, 2011, the company had a total of 1,155 stores, including 986 BBB stores, 70 CTS stores, 54 buybuy BABY stores, and 45 Harmon stores in 50 states, the District of Columbia, Puerto Rico, and Canada. It also operates two stores under the name of Home & More in the Mexico City through a joint venture. Bed Bath & Beyond Inc. was foun ded in 1971 and is based in Union, New Jersey.
Advisors' Opinion:- [By Ben Levisohn]
Bed Bath & Beyond (BBBY) has gained 0.9% to $59.89 as a big share repurchase trumped a BofA Merrill Lynch Underperform from Neutral.
Tesla (TSLA) has dipped 0.9% to $227.27 after a stolen Tesla Model S was split in two and burst into flames following a high speed chase.
Top 5 Services Companies To Buy Right Now: Entest Biomedical Inc (ENTB)
Entest BioMedical, Inc. (Entest), incorporated on September 24, 2008, is a development-stage company. During the fiscal year ended August 31, 2012, the Company�� business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is focusing its research and development efforts toward the development and commercialization of the ImenVax family of canine cancer vaccines. ImenVax I is a therapeutic for canine cancer, which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. ImenVax II, which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses.
ImenVax
The Company is conducting a ten dog safety study to Evaluate ImenVax I for the Treatment of Canine Oral Melanoma. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.
ImenVax II
The Company intends to include adjuvant cytokine along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line.
ImenVax III
ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax III is intended to treat existing tumors through stimulation of immune responses to kill tumor cells directly; indirectly kill tumor cells by cutting off the tumor blood supply, and block the ability of the tumor to suppress the immune system.
ENT-576
ENT-57 is a therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD), such therapy consists of extracting a therapeutic number of cells from a tissue containing in part a stem cell population; processing sai! d population of cells derived from said tissue so as to concentrate said stem cell population; systemic re-administration of said cell population into the same patient, and exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration.
Advisors' Opinion:- [By Bryan Murphy]
The so-called fundamentals, frankly, don't really matter for Entest BioMedical Inc. (OTCMKTS:ENTB) or Gevo, Inc. (NASDAQ:GEVO). Oh, both GEVO and ENTB are generating sales, but both are consistently taking losses. That's ok though, as for both companies right now, profits aren't really the point - it's the pipeline that matters.
No comments:
Post a Comment